Butterfly Network Lands Multi-Year Bridge Neurotech Deal
Butterfly Network and Bridge Neurotech partner to build a non-invasive, ultrasound-based brain-computer interface (BCI) using AI decoding.
Stocks · News reference
Canaccord Genuity Initiates Coverage On Butterfly Network with Buy Rating, Announces Price Target of $10
Canaccord Genuity analyst William Plovanic initiates coverage on Butterfly Network (NYSE:BFLY) with a Buy rating and announces Price Target of $10.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bridge Neurotech, Butterfly Network Announce Research, Development Agreement
Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a
8-K filing — Butterfly Network, Inc. (BFLY)
Filed: 2026-10-05 AccNo: 0001804176-26-000033 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits